- Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma2023 | Faculty of Medicine in Pilsen
- Multidisciplinary approach to the lung adenocarcinoma treatment in a young patient2019 | Third Faculty of Medicine
- Vanadocene complexes bearing N,N'-chelating ligands: Synthesis, structures and in vitro cytotoxic studies on the A549 lung adenocarcinoma cell line2019 | Faculty of Medicine in Hradec Králové, Faculty of Science
- Systemic therapy of lung adenocarcinoma2016 | Faculty of Medicine in Pilsen
- Long time successful treatment of a young patient suffering from advanced ALK rearreged lung adenocarcinoma2018 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Lung adenocarcinoma with two simultaneous driving mutations2013 | Faculty of Medicine in Pilsen
- Current Two EGFR Mutations in Lung Adenocarcinoma - Case Report2015 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Lorlatinib in a pretreated patient with ALK-positive lung adenocarcinoma2021 | Third Faculty of Medicine
- Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Identification and Development of a Lung Adenocarcinoma PDX Model With STRN-ALK Fusion2019 | Faculty of Medicine in Hradec Králové
- Lung adenocarcinoma with a rare EGFR mutation and infrequent resistance to treatment2022 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression2016 | Central Library of Charles University
- The Use of CT Pattern in Differentiating Non-invasive, Minimally Invasive and Invasive Variants of Lung Adenocarcinoma2021 | Faculty of Medicine in Pilsen
- Czech patient with lung adenocarcinoma with the BRAF V600E mutation succesfully treated with dabrafenib plus trametinib2021 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Sequential Treatment of Advanced-stage Lung Adenocarcinoma Harboring Wild-type EGFR Gene: Second-line Pemetrexed Followed by Third-line Erlotinib versus the Reverse Sequence2013 | Faculty of Medicine in Pilsen
- Molecular pathology of lung cancer in routine diagnostic practice: 2017 update2017 | First Faculty of Medicine
- CT findings in lung adenocarcinhoma with lepidic growth2018 | Faculty of Medicine in Pilsen
- Molecular pathology of pulmonary carcinomas2014 | Third Faculty of Medicine
- Pancracine, a Montanine-Type Amaryllidaceae Alkaloid, Inhibits Proliferation of A549 Lung Adenocarcinoma Cells and Induces Apoptotic Cell Death in MOLT-4 Leukemic Cells2021 | Faculty of Medicine in Hradec Králové
- A targeted diagnostic procedure and a treatment of an advanced lung carcinoma -the case report of a successful cooperation of four clinic departments, and crizotinib in a treatment of ROS 1 positive NSCLC2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer2015 | First Faculty of Medicine
- Superoxide Dismutase and Nicotinamide Adenine Dinucleotide Phosphate Quinone Oxidoreductase Polymorphisms and Pancreatic Cancer Risk2011 | First Faculty of Medicine
- Superoxide Dismutase and Nicotinamide Adenine Dinucleotide Phosphate Quinone Oxidoreductase Polymorphisms and Pancreatic Cancer Risk2011 | Second Faculty of Medicine
- Osimertinib in treating advanced non-squamous non-small cell lung cancer2022 | First Faculty of Medicine
- Avastin: a case report2010 | Faculty of Medicine in Pilsen
- Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database2021 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Nintedanib - interesting alternative forsecond line pulmonaty adenocarcinoma patients2016 | Faculty of Medicine in Pilsen
- Tumor-to-tumor metastasis: Warthin tumor as a recipient of lung carcinoma and of renal carcinoma - Report of wo cases2010 | Faculty of Medicine in Hradec Králové
- Successful Therapy of Czech Patients with ROS1 Translocation by Crizotinib2016 | Faculty of Medicine in Pilsen
- New WHO classification of lung tumours2016 | Faculty of Medicine in Pilsen